julianzchen

Forum Replies Created

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • July 10, 2017 at 10:09 am in reply to: Votrient (pazopanib) working wiht FGFR2 mutation #94961
    julianzchen
    Member

    Cary,

    Thanks for sharing your father’s story and am so happy to hear that Pazopanib works for him on behalf of FGFR2. I hopw he will soon find new option at MDA.

    May I ask if there is any metastasis at the time he was treated for iCCA with Pazopanib. Thanks!

    My sister-in-law carries ICCA and is at metastatic stage. I was wondering if Pazopanib will work for her even if she is positive with FGFR2.

    Thanks!

    Julian

    April 16, 2017 at 3:32 pm in reply to: Long overdue update! #94066
    julianzchen
    Member

    Kathy,

    Glad that you feel well! Thank you for sharing your experience. I just joined the board because my sister-in-law in China was just diagnosed of ICC.

    Sounds that pazopanib targets FGFR2 mutation (or FGFR2 fusion protein?). Is the the FGFR2 thing related to ICC or more NSCLC in your case?

    Julian, Bosotn

  • Author
    Posts
Viewing 2 posts - 1 through 2 (of 2 total)